Cholesterol favors the anchorage of human dystrophin repeats 16 to 21 in membrane at physiological surface pressure. by Ameziane-Le Hir, Sarah et al.
Cholesterol favors the anchorage of human dystrophin
repeats 16 to 21 in membrane at physiological surface
pressure.
Sarah Ameziane-Le Hir, Ce´line Rague´ne`s-Nicol, Gilles Paboeuf, Aure´lie
Nicolas, Elisabeth Le Rumeur, Ve´ronique Vie´
To cite this version:
Sarah Ameziane-Le Hir, Ce´line Rague´ne`s-Nicol, Gilles Paboeuf, Aure´lie Nicolas, Elisabeth Le
Rumeur, et al.. Cholesterol favors the anchorage of human dystrophin repeats 16 to 21 in
membrane at physiological surface pressure.. BBA - Biomembranes, Elsevier, 2014, 1838 (5),
pp.1266-73. <10.1016/j.bbamem.2014.01.010>. <hal-00965782>
HAL Id: hal-00965782
https://hal.archives-ouvertes.fr/hal-00965782
Submitted on 13 Jun 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

 1 
Cholesterol favors the anchorage of human 
dystrophin repeats 16 to 21 in membrane at 
physiological surface pressure 
Sarah Ameziane Le Hir1,2,3,4, Céline Raguénès-Nicol1,3,4, Gilles Paboeuf1,2,4, Aurélie 
Nicolas1,3,4, Elisabeth Le Rumeur1,3,4 and Véronique Vié1,2,4*. 
1 Université de Rennes 1, 35042 Rennes, France. 2 UMR CNRS 6251, Institut de physique de 
Rennes, Campus Beaulieu, F-35042 Rennes. 3 UMR CNRS 6290, Equipe SIM, Campus 
Villejean, F-35043 Rennes. 4 Université Européenne de Bretagne, 5 boulevard Laënnec, F-
35000 Rennes. 
 
KEYWORDS  
Atomic force microscopy, Langmuir film, muscular dystrophy, protein lipid interaction, 
CRAC sequence, spectrin superfamily  
 
ABSTRACT  
Dystrophin (DYS) is a filamentous protein that connects the cytoskeleton and the 
extracellular matrix via the sarcolemma, conferring resistance to muscular cells. In this study, 
interactions between the DYS R16-21 fragment and lipids were examined using Langmuir 
films made of anionic and zwitterionic lipids. The film fluidity was modified by the addition 
of 15% cholesterol. Whatever the lipid mixture examined, at low surface pressure (20 mN/m) 
few differences appeared on the protein insertion and the presence of cholesterol did not 
affect the protein/lipid interactions. At high surface pressure (30 mN/m), the protein insertion 
was very low and occurred only in zwitterionic films in the liquid-expanded phase. In anionic 
films, electrostatic interactions prevented the protein insertion outright, and caused 
accumulation of the protein on the hydrophilic part of the monolayer. Addition of cholesterol 
to both lipid mixtures drastically modified the protein-lipid interactions: the DYS R16-21 
insertion increased and its organization in the monolayer appeared to be more homogeneous. 
The presence of accessible cholesterol recognition amino-acid consensus sequences in this 
fragment may enhance the protein/membrane binding at physiological lateral pressure. These 
results suggest that the anchorage of dystrophin to the membrane in vivo may be stabilized by 
cholesterol-rich nano-domains in the inner leaflet of sarcolemma. 
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SUPPLEMENTARY TABLE S1 
 
Summary of values obtained after protein insertion in lipid monolayers and described in the 
text: surface pressure (∆π) and ellipsometric angles (δ∆) variations; apparent height of 
protein protrusions in AFM images. 
 
πi = 20 mN/m 
 
 ∆π δ∆ Height (nm) 
 - CHOL + CHOL - CHOL + CHOL - CHOL + CHOL 
DOPC/DOPS 5 ± 0.1 5 ± 0.3 1.2 ± 0.3 1.1 ± 0.1 2.1 ± 0.2 2.7 ± 0.1 
DOPC/DPPC 5 ± 0.1 5.9 ± 0.3 1.3 ± 0.1 1.7 2 ± 0.1 3.1 ± 0.2 
 
 
πi = 30mN/m 
 ∆π δ∆ Height (nm) 
 - CHOL + CHOL - CHOL + CHOL - CHOL + CHOL 
DOPC/DOPS -1.6 ± 0.2 2.0 ± 0.1 0.6 ± 0.2 0.2 ± 0.1 3.6 ± 0.4 2.3 ± 0.1 
DOPC/DPPC 0.3 ± 0.2 2.0 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 1.1 à 4 2.6 ± 0.2 
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SUPPLEMENTARY TABLE S2 
 
Occurrences of CRAC sequences (L/V)–(X)1–5–Y–(X)1–5–(R/K) in the primary sequences of 
dystrophin (uniprot P11532), alpha erythroid spectrin (uniprot P02549), and beta erythroid 
spectrin (uniprot P11277) as determined by protein pattern find tool of Sequence 
Manipulation Suite (Stothard, 2000. Biotechniques 28:1102-1104). Amino acids of CRAC 
sequences are in blue, sometimes several patterns are overlapped. 
 
DYSTROPHIN 
 
SPECTRIN A 
 
SPECTRIN B 
 
ABD 1 
 
Hinge 1 
Repeat 1 
Repeat 2 
Repeat 3 
Hinge 2 
Repeat 4 
Repeat 5 
Repeat 6 
 
Repeat 7 
Repeat 8 
Repeat 9 
Repeat 10 
Repeat 11 
Repeat 12 
Repeat 13 
Repeat 14 
Repeat 15 
Repeat 16 
Repeat 17 
Repeat 18 
Repeat 19 
Hinge 3 
Repeat 20 
Repeat 21 
Repeat 22 
Repeat 23 
Repeat 24 
Hinge 4 
Cys-rich 
 
 
C-term 
V7EDCYER13 
V218DTTYPDKK226 
V280SLAQGYER288  
- 
- 
- 
- 
- 
- 
L967SVTDYEIMEQR978 
L996YYLSTTVK1004 
- 
L1243TTNYQWLCTR1253 
L1271LSYLEKANK1280  
L1393AAYIADK1400  
L1548KLHYNELGAK1558 
L1671NLLLEYQK1679 
- 
- 
- 
V2088NKMYKDRQGR2098 
- 
- 
- 
- 
- 
L2645KLLRDYSADDTR2657 
- 
L2881EKLYQEPR2889 
- 
V3101RFSAYRTAMK3111 
L3154TTIYDR3160  
L3182LNVYDTGR3190  
L3211EDKYRYLFK3220 
L3520QAEYDRLK3528 
 
 
 
Repeat 1 
Repeat 2 
Repeat 3 
Repeat 4 
 
Repeat 5 
Repeat 6 
Repeat 7 
Repeat 8 
Repeat 9 
Repeat 10 
SH3 
 
Repeat 11 
Repeat 12 
Repeat 13 
Repeat 14 
Repeat 15 
Repeat 16 
Repeat 17 
Repeat 18 
Repeat 19 
Repeat 20 
Repeat 21 
EF-hand 1 
EF-hand 2 
EF-hand 3 
 
 
 
V31LTRYQSFKER41 
L49EDSYHLQVFK59 
- 
V286LTSEDYGK294 
L358ATSRYEK365 
L366QATYWYHR374 
L542IGDDHYDSENIK554 
- 
V710TSEDYGK717 
- 
- 
V982MALYDFQAR991 
V1026PAVYVRR1033 
- 
- 
- 
L1460IADEHYAK1468 
L1496GDYANLK1503 
- 
V1736SSQDYGR1743 
- 
- 
- 
- 
- 
- 
L2364AEGKSYITK2373 
ABD 
SH1 
SH2 
Repeat 1 
 
Repeat 2 
 
Repeat 3 
Repeat 4 
Repeat 5 
Repeat 6 
Repeat 7 
Repeat 8 
Repeat 9 
Repeat 10 
Repeat 11 
Repeat 12 
Repeat 13 
Repeat 14 
 
Repeat 15 
Repeat 16 
Repeat 17 
V10GNQPPYSRINAR22 
- 
- 
V270VAFYHYFSKMK281 
L341QAFSTYRTVEK352 
L399EEAEYRR406 
L488EKENYHDQKR498 
- 
L663DYGK667 
- 
- 
- 
- 
V1235AEGNLYSDKIK1246 
V1300SYDEAR1306 
- 
- 
V1633EDYGRNIK1641 
V1668DKHYAGLK1676 
L1686ENMYHLFQLK1696 
L1792LAASYDLHR1801 
L1862QTAYAGEK1870  
- 
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1. Introduction 
Dystrophin (DYS) is a long filamentous muscular protein of 427 kDa (about 175 nm long) 
[1, 2]. Most of this length is due to a long central rod domain composed of 24 spectrin-like 
repeats (R1 to R24) folded into a triple-α-helical bundle [3]. The biological function of 
dystrophin is to protect the membrane against stress during elongation/contraction muscular 
cycles. Its absence leads to the severe disease Duchenne muscular dystrophy (DMD), 
whereas the milder Becker muscular dystrophy (BMD) may be observed when truncated 
proteins are expressed [4]. Due to its high levels of STRs, dystrophin is a member of the 
spectrin-like superfamily [5]. A relationship has been suggested between the structural 
organization of the repeat domains in these proteins and the membrane’s protection against 
shearing stresses [3]. This function may result from a homogeneous protein distribution along 
the membrane caused by protein/lipid interactions. Indeed, spectrin is known to bind to the 
inner membrane leaflet due to interactions with phosphatidylserine [6-9]. Moreover the 
presence of 10-20% cholesterol (CHOL) facilitates the insertion of spectrin into 
phosphatidylethanolamine/phosphatidylcholine monolayers that were preformed at low 
surface pressure, i.e. from 8 to 11 mN/m [10]. Even during its liquid-expanded phase (LE), 
spectrin binding capacity depends on the fluidity of the monolayer. Our previous studies 
showed that fragments of the dystrophin rod domain interact with membrane system models 
through electrostatic and/or hydrophobic forces [11, 12]. 
This study is focused on the interaction of the specific dystrophin fragment made of 
repeats R16 to R21 and a membrane model. This construct has several specific features that 
set it apart from other dystrophin fragments. For instance, it contains a hinge (H3) between 
the repeats R19 and R20 [13, 14]. The presence of H3 in microdystrophin improves the 
capacity for muscle degeneration prevention, while deletion of this hinge leads to the BMD 
phenotype [15, 16]. In addition, DYS R16-21 is coded by exons 42 to 53, which includes the 
hot-spot between exons 45 to 53 where about one third of BMD patients have mutations [17]. 
The fragment also mediates specific protein interactions, such as the anchoring of neuronal 
NO Synthase (nNOS) to the sarcolemma through R16-R17 [18]. The mislocalisation of 
nNOS in the membrane leads to a decrease of muscular strength in dystrophin-deficient mdx 
mice [19]. R16-21 is located in the last part of the protein, where the cysteine-rich domain is 
known to bind to β-dystroglycan (β-DG) in a membrane protein complex [20] that is located 
in detergent-resistant membrane. Sarcolemmal CHOL depletion induces the weakening of 
force contractions through the redistribution of β-DG, and is accompanied by a reduction of 
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β-DG/dystrophin interactions in favor of β-DG/caveolin-3 interactions [21]. All these studies 
showed that structural or lipid environmental modifications impact muscular activity. 
Nevertheless, up to now little was known about the ability of DYS R16-21 to interact with 
lipid membranes.  
Here, we address the question of the DYS R16-21 anchorage in mixed lipid films and 
more particularly of the effect of CHOL on the interaction. Since phosphatidylserine is 
specifically abundant in the inner leaflet of the sarcolemma membrane, the effect of the polar 
head charge was tested using a simplified mixture composed of anionic 
dioleoylphosphatidylserine (DOPS) and zwitterionic dioleoylphosphatidylcholine (DOPC) 
lipids. Because we chose unsaturated lipids, the monolayers are in the LE phase regardless of 
the surface pressure. A mix of dipalmitoylphosphatidylcholine (DPPC) and DOPC was used 
to mimic a detergent-resistant membrane as described [22, 23]. Indeed DPPC has been 
reported to form liquid-condensed (LC) phase domains and also to create separated phases 
when mixed with DOPC [24]. Cholesterol, also present in the inner leaflet up to 25% [25], is 
known to modulate membrane fluidity, and particularly at high surface pressure, it acts as a 
head group spacer because of its molecular orientation in the monolayer. Moreover, CHOL is 
located mainly in the condensed phase formed by DPPC [26, 27]. Langmuir monolayers were 
used, which allowed for control of charge densities, of fluidity, and of lipid packing 
according to specific lipid compositions and surface pressures. Protein-lipid interactions and 
protein structure were determined by combining tensiometric and ellipsometric 
measurements with atomic force microscopy imaging. We evaluated the influence of 15% 
CHOL on the interaction of DYS R16-21 with DOPC/DOPS and DOPC/DPPC lipid 
mixtures. Using two initial surface pressures, two different lipid packings were tested The 
higher of these (30 mN/m) is considered to be comparable to physiological membrane 
pressure [28, 29].  
Our results show that DYS R16-21 interacts with the lipid monolayer no matter what 
mixture was used, while the surface pressure has a notable impact on the insertion. In 
addition, under high surface pressure CHOL was shown to stabilize the fragment at lipid 
interface, likely through the presence of two cholesterol recognition amino-acid consensus 
(CRAC) sequences on the protein surface [30]. The presence of CRAC sequences all along 
dystrophin allows specific protein/lipid interactions that result in homogeneous protein 
distribution along the membrane. This anchorage could be related to lateral force 
transmission during muscle elongation/contraction. 
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2 Experimental sections 
2.1 Materials 
All lipids were purchased from Avanti Polar Lipids (Alabama, US). The pGEX-4T-1 
plasmid vector and GSTrap HP and Sephacryl S-100 columns were bought from GE 
Healthcare. BL21 bacteria and restriction enzymes were purchased from Ozyme (St.-
Quentin-en-Yvelines, France). Purified bovine thrombin came from Stago (Asnières-sur-
Seine, France). 
2.2 Preparation of recombinant DYS R16-21 protein 
The DYS R16-21 fragment begins at residue Ser 1994 and ends with Thr 2686, using the 
full-length human dystrophin annotation (NCBI NP_003997). In order to improve stability 
and as previously done for other dystrophin fragments [31, 32], we included a three-amino-
acid extension in the N-terminus and a seven-amino-acid extension in the C-terminus. The 
protein was cloned in pGEX-4T-1 then expressed in a protease-deficient E. coli BL21 strain 
as a GST-tagged protein [33]. Cell lysis was obtained by sonication after lysozyme treatment. 
DYS R16-21 was further purified using GST affinity chromatography. After thrombin 
proteolysis (50 UI for 2 hours at room temperature), the chromatography fractions were 
separated by salting-out with ammonium sulfate. The target protein was collected at 24% salt 
saturation and rediluted in TNE buffer (20 mM Tris, 150 mM NaCl, 0.1 mM EDTA, pH 7.5). 
Purification was achieved with size-exclusion chromatography by passing it through a 
Sephacryl S-100 column (L 2.6 cm x H 60 cm) at 1 mL/min using the same buffer. After 
purification, the protein was concentrated using a 30 kDa cut-off centrifugal concentrator. 
Purity was assessed by 10% SDS-Polyacrylamide gel electrophoresis (SDS-PAGE), and 
concentration was determined using a bicinchoninic acid assay with a standard of serum 
albumin.  
Circular dichroism spectra were acquired between 250 nm and 200 nm, with 1.5 µM of 
protein in TNE buffer at 20°C (J-815, Jobin-Yvon) using 0.2 cm path-length cells. The α-
helical content was calculated from the mean molar residue ellipticity [θ] (mdeg.cm2.dmol-1) 
at 222 nm [34]. 
2.3 Tensiometric and ellipsometric measurements 
In order to investigate the interfacial properties of the protein with and without lipids, 
surface pressure and ellipsometric angles were measured in Teflon troughs (4, 8, or 60 mL) at 
20°C. The Wilhelmy method was used to determine the surface pressure using a tensiometer 
(Nima Technology, Cambridge, UK). Ellipsometric measurements were performed with a 
conventional polarizer-analyzer null-ellipsometer setup. Briefly, a He-Ne laser (632.8 nm; 
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Melles Griot, Carlsbad, CA) with an angle of incidence of 52.18° (1° away from the 
Brewster’s angle),  was used as the light source. Reflecting surface properties were explored 
by recording the positions of the polarizer and analyzer having the minimal intensity of 
transmitted light. The analyzer angle was doubled to yield the value of the ellipsometric angle 
(Δ)  [35-37]. Both Δ and the surface pressure (π) were recorded as functions of time. The 
amphiphilic character was determined by reporting the surface pressure reached at this end of 
the absorption kinetics as a function of the protein’s subphase concentrations (ranging from 
0.0001 µM to 1 µM). For lipid/protein experiments, the lipid mixtures (DOPC/DOPS 1:1 
molar ratio and DOPC/DPPC 1:1 molar ratio) were prepared in a 2:1 chloroform/methanol 
solution (v/v) at 0.5 mM, and where used, CHOL was added at 15% (molar ratio). The lipids 
were gently spread at the air/liquid interface of the TNE subphase at the desired surface 
pressure. These initial lipid surface pressures (πi) ranged from 5 to 35 mN/m. At a final 
concentration of 0.03 µM, the protein was then injected into the subphase just beneath the 
lipid monolayer. The variations (δΔ and Δπ) induced by protein adsorption at the end of the 
absorption kinetics were reported as functions of time and πi. Each experiment was repeated 
up to four times and means ± standard deviation (SD) were provided for each series. The 
temperature varied between 19 and 21ºC. 
2.4 Atomic force microscopy (AFM) observations 
The interfacial film was transferred onto a freshly-cleaved mica plate using the Langmuir-
Blodgett technique. The experiment was realized using a 102 cm² Langmuir trough equipped 
with two movable barriers and controlled by a computer (model 601 M, Nima Technology, 
Cambridge, UK). The transfer was performed at the end of the kinetics and at a constant 
surface pressure. The dipper speed rate was 1 mm/min. Transferred monolayers were imaged 
using a PicoPlus atomic force microscope (Agilent Technologies, Phoenix, AZ) equipped 
with a 10 μm scanner operating in contact mode. Images were acquired under ambient 
conditions using silicon nitride tips on integral cantilevers (ScienTec) with a spring constant 
of 0.06 N/m. For each measurement, the set point was adjusted before and during the 
scanning to minimize the force between the tip and the sample. In each case, images were 
obtained from at least two samples prepared on different days, with at least four 
macroscopically-separated areas in each sample. To determine the height of the objects, after 
processing the images with Gwyddion 2.26 software (http://gwyddion.net) we did a statistical 
analysis. Objects of interest were selected by threshold, and then areas and maximal heights 
were determined. The values of height versus area were plotted, resulting in a plateau. This 
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plateau included the majority of the objects and was used to compare the different 
experimental conditions. 
 
2.5 Three-dimensional molecular homology modeling and surface properties 
Three-dimensional (3D) homology models were obtained using I-TASSER server [38]. As 
previously described [39], the sequences of two successive repeats (“tandem repeats”) with 
an overlap of a single repeat were submitted to I-TASSER (e.g. DYS R16-17, then DYS R17-
18, and so on). The H3 sequence was submitted separately. Superposition of the shared repeat 
of two successive tandem repeats allowed the construction of an extended model which we 
further minimized by YASARA (e.g. the DYS R16-17 and DYS R17-18 models were used to 
construct a DYS R16-18 model). In this way, step by step, the global 3D structure was 
reconstructed. Surface hydrophobicity was calculated using PLATINUM [40] and surface 
electrostatic potentials in the presence of 50 mM NaCl were calculated using the Adaptive 
Poisson-Boltzmann Solver (APBS) software [41]. Visualization was done using VMD and 
PyMOL. 
 
 
3. Results  
3.1 Protein purification  
SDS-PAGE of the recombinant human dystrophin fragment DYS R16-21 (figure 1A) 
showed the protein at the expected molecular weight of 80 kDa. As expected with spectrin-
like repeats [11, 42], the circular dichroism spectrum of DYS R16-21 displayed the typical 
predominant α-helix folding with two minima at 208 and 222 nm (figure 1B). Per Chen et al., 
the molar ellipticity of 222 nm allowed for determination of an α-helix content of 83% [43]. 
The ratio of the molar ellipticity at 222 and 208 nm (θ222/θ208) was 1.05, indicating that the 
helices were interacting and folded in a coiled-coil [44]. Therefore, it appears that the 
recombinant DYS R16-21 fragment was highly purified and correctly folded, conditions 
necessary for its further study. 
 
3.2 Amphiphilic properties of DYS R16-21 
For each DYS R16-21 subphase concentration between 0.0001 to 1 µM, surface pressure 
measurements were done and the final surface pressure versus subphase protein 
concentrations are reported in figure 2A. As the protein concentration increased, π increased 
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until a plateau (πmax) of 21 mN/m was reached, indicating the amphiphilic character of DYS 
R16-21. From these adsorption kinetics results, the critical concentration required for 
interface saturation was determined to be 0.1 µM. For further experiments, a protein 
concentration of 0.03 µM (or 2.5 µg/mL) was chosen (indicated with an arrow in figure 2A) 
to avoid a potential aggregation of proteins in the subphase or the formation of multilayers at 
the interface. Figure 2B shows a typical adsorption time for this protein concentration. 
Whereas surface pressure is related to the protein’s ability to cover the interface and to 
interact laterally, the ellipsometric angle depends on the amount of matter at the interface. As 
is usual, at the very beginning of the adsorption the ellipsometric angle increased quicker 
than the surface pressure. It reached an angle of 10° at equilibrium, a value corresponding to 
a monolayer as experienced in  other proteins [45]. AFM imagery of this monolayer at the 
end of the adsorption kinetics (figure 2C) showed a homogeneous film with no aggregation.  
 
3.3 DYS R16-21 interaction with lipid monolayers  
The adsorption kinetics of DYS R16-21 was monitored at various initial lipid surface 
pressures (πi). The variations of the surface pressure (Δπ) i.e. the difference between the 
initial lipid surface pressure and the final surface pressure were reported as a function of πi 
(figure 3). When πi increased, Δπ induced by adsorption of DYS R16-21 decreased. Indeed as 
the lipids compacted, the protein was less and less able to be inserted into the lipid 
monolayer. When there was no more variation between the initial and final surface pressures 
(Δπ=0 or intercept of the linear regression with the x axis as indicated with arrows in figure 
3), the maximal insertion pressure (MIP) was reached [46]. This was clearly dependent on the 
lipid mixture, with values of 26.5 mN/m for DOPC/DOPS and 33 mN/m for DOPC/DPPC.  
For πi less than 20 mN/m, ∆π was higher with anionic than with zwiterrionic lipids, 
suggesting an attractive role for electrostatic interactions in the insertion of DYS R16-21. On 
the other hand, when πi was higher than 20 mN/m, ∆π was higher with zwitterionic lipids, 
suggesting presence of hydrophobic interactions during the protein’s insertion process, while 
electrostatic interactions limit the insertion. Moreover, for the DOPC/DOPS monolayer at an 
initial surface pressure higher than πe (26 mN/m), the protein induced a surface pressure 
decrease (∆π = -1.6 mN/m), thus showing that attractive interactions were still taking place 
between DYS R16-21 and the compacted DOPC/DOPS monolayer.  
To further analyze the organization of DYS R16-21 in lipid environments, we focused our 
work on lipid monolayers formed at two significant initial surface pressures: 20 mN/m, where 
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the protein adsorption induced similar overpressures for all lipid compositions tested; and 30 
mN/m, considered to be close to physiological membrane pressure [29]. All reported values 
are recapitulated in table S1. 
 
3.4 Cholesterol has few effects at a πi of 20 mN/m  
Cholesterol is known to influence lipid packing therefore we studied the impact of 15 % 
CHOL on the DYS R16-21/lipid interactions. At πi of 20 mN/m (figure 4A), no changes were 
observed upon the addition of CHOL to the DOPC/DOPS film, while there was a slight 
increase of ∆π and δ∆ (1 mN/m and 0.4° respectively) in the DOPC/DPPC mixture. AFM 
images of pure lipid films were unmodified in the presence of CHOL. DOPC/DOPS ± CHOL 
(figure 4B) formed a homogeneous liquid-expanded (LE) phase. DOPC/DPPC ± CHOL 
images (figure 4E) showed the coexistence of an LE phase of DOPC and a liquid-condensed 
(LC) phase of DPPC, as previously observed [47]. The LC domains were several µm in 
diameter and their apparent height was 1.4 ± 0.1 nm. 
Mixed protein/lipid films showed bright protrusions attributed to the protein’s presence 
(figure 4C-H). In DOPC/DOPS ± CHOL films, these protrusions appeared mostly as worm-
like curved filaments (figure 4C-D). CHOL induced both protein clustering and an increase in 
the apparent height of protrusions (2.1± 0.1 nm without CHOL versus 2.7± 0.1 nm with 
CHOL). These changes in DYS R16-21 organization occurred even though the lateral 
pressure and the amount of material at the interface were similar with or without CHOL 
(figure 4A).  
In DOPC/DPPC films (figure 4E-H), the presence of DYS R16-21 drastically decreased 
the LC domain’s diameter, which never exceeded 400 nm. Without CHOL (figure 4F-G), the 
proteins appeared as round objects or filaments with heights higher (2.0 ± 0.1 nm) than those 
of LC domains (1.4±0.1nm). The filaments were most often stuck to an LC phase (detailed 
view, figure 4G) whereas round objects were located in an LE phase. In the presence of 
CHOL (figure 4H), higher filaments (3.1 ± 0.2 nm) were located both in the LE phase and at 
the boundaries of LE/LC phases. 
 
3.5 Cholesterol increases DYS R16-21 insertion at a πi of 30 mN/m  
Ellipsometric and tensiometric measurements (figure 5A) showed that in any lipid 
condition, a πi of 30 mN/m induced the presence of less protein at the interface than with a πi 
of 20 mN/m. Injection of DYS R16-21 under the DOPC/DOPS/CHOL monolayer led to an 
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increase in surface pressure (from -1.6 mN/m without CHOL to +2 mN/m with CHOL) and a 
decrease in the ellipsometric angle (from 0.6° without CHOL to 0.2° with CHOL), indicating 
modified protein/lipid interactions that favor the insertion of DYS R16-21. In the 
DOPC/DPPC films, the presence of CHOL had no significant effects on ellipsometric angle 
variation after injection of DYS R16-21, whereas the presence of CHOL induced an increase 
in ∆π (from 0.3 mN/m without CHOL to 2 mN/m).  
The AFM images of DOPC/DOPS films with or without CHOL (figure 5B) were similar 
to those at 20 mN/m. The DOPC/DPPC/CHOL AFM images revealed that the presence of 
CHOL caused a slight decrease in height of LC domains (from 1.4 nm without CHOL to 
1.2 nm) (figure 5E).  
In the DOPC/DOPS/protein films (figure 5C), DYS R16-21 appeared as protrusions 
forming heterogeneous clusters higher (3.6 ± 0.4 nm) and larger than those previously 
observed at a πi of 20 mN/m. This is consistent with the variations in surface pressures and 
ellipsometric angles seen with the two surface pressures (figure 4A and 5A). In the presence 
of CHOL (figure 5D), the proteins formed small protrusions that are smaller in length, width, 
and height (2.3 nm ±0.1) than those in the absence of CHOL or with a smaller πi. Finally, the 
protein organization was more homogeneous, with deeper insertion into the lipid monolayer 
and less material at the interface.  
In DOPC/DPPC/protein films (figure 5F), the protein was present as scarce clusters in 
agreement with the low ∆π. Their heights (between 1 and 4 nm), were very heterogeneous. 
By contrast, CHOL induced numerous clusters of DYS R16-21 (figure 5G-H) with heights of 
2.6 ± 0.2 nm. The LC domain borders were much more irregular and angular than without 
CHOL. The protein clusters appear to be more elongated when in contact with LC domains 
than when embedded in LE domains (detailed view, figure 5H). Some objects also appeared 
to be embedded in LC domains, but since there was a depression surrounding these clusters it 
was obvious that there was no direct contact between the LC and the protein.  
 
3.6 Computational analysis of DYS R16-21in presence of 50 mM NaCl 
As expected for a soluble protein, the molecular surface of DYS R16-21 is mainly 
hydrophilic. Nevertheless one side of the fragment displays a higher presence of hydrophobic 
amino acids (figure 6). The electrostatic potential at the molecular surface shows a 
distribution of negative and positive charges along the molecule. Numerous positive patches 
were observed, mainly on repeats 16 and 17 of DYS R16-21, with the rest dispersed more 
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widely along the molecule and embedded in the negative surface. A rotated view of the 
fragment showed a more contrasted surface with larger negative patches, separated by a few 
small positive zones that appear mostly on repeats 18 and 19. Interestingly, some 
hydrophobic patches colocalize or are very close to the cationic surface (for example on R16, 
R18 and R20). These may thus be anchorage points for interaction or insertion in anionic and 
zwitterionic lipid monolayers even under high initial surface pressures.  
A search of the primary sequence of dystrophin revealed several occurrences of the 
CRAC pattern –(L/V)–(X)1–5–Y–(X)1–5–(R/K)- [30]. Due to this sequence, a cholesterol 
binding cleft is created where Y and R/K interact directly with CHOL [48]. In DYS R16-21, 
the pattern was found in the C helix of R16 (V2088NKMYKDR2098) and in the R21 B-C loop 
(L2647RDYSADDTR2657) (figure 6). Most of the amino acids involved are exposed on the 
surface, and accessible enough to enable interaction with CHOL molecules.  
 
4. Discussion 
In this study, we examine the interaction of DYS R16-21 with lipid monolayers . This 
particular dystrophin fragment is characterized by the presence of hinge 3 (H3) and is 
frequently mutated in patients. DYS R16-21 displayed amphiphilic properties that were 
probably due to the presence of hydrophobic amino-acids all along the surface (figure 6). 
Compared with previously-studied rod domain fragments, the adsorption of DYS R16-21 at 
the air/water interface was faster,the plateau was reached at a smaller protein concentration 
but has a similar value of 21 mN/m [12, 49]. This indicates both that the interface is more 
rapidly covered by the protein, and that the molecules do indeed interact with each other. 
This result could be related to the larger size of the protein as compared to other dystrophin 
fragments previously studied, and/or to the presence of H3, which may make the protein’s 
structure more flexible [13]. 
The monolayer’s initial lipid surface pressure (πi) is a major factor influencing the 
adsorption of amphiphilic proteins through electrostatic or hydrophobic forces because it 
determines lipid packing. When πi was below 20 mN/m, the protein was able to insert itself 
into both anionic and zwitterionic monolayers; however the maximal insertion pressure was 
significantly lower for the anionic mixture suggesting that attractive electrostatic interaction 
plays a major role in DYS R16-21-membrane interactions. The negative charge of the polar 
head attracts the protein toward the membrane, allowing further hydrophobic interactions to 
occur thanks to free interfacial space. At a πi of 20 mN/m, the protein insertion overpressures 
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and ellipsometric angle variations seem to be equivalent for both lipid mixes. AFM 
observations show the protein as round or fibrous objects with regular heights (about one 
protein thick). The fibrous objects were present in the anionic mix, and interconnected 
filaments were only detected in contact with LC domains. These features imply that the 
molecules were stabilized at the interface by negative charges or LC domains and then 
adopted the same orientation at the lipid interface. This favors the existence of lateral 
protein/protein interactions in both lipid mixtures. At a πi over 20 mN/m, electrostatic 
interactions still occur but the space between lipid head groups becomes more and more 
limited, and the fragment insertion slows. Finally, when the πi of the DOPC/DOPS film was 
over 26 mN/m, interactions with lipid head groups caused a reorientation and relaxation of 
the films, as shown by a decrease in the final surface pressure, and the protein appears as 
irregular clusters. This phenomenon has been reported previously for the dystrophin R2 
repeat [50], DYS R20-24 [12] and in α-spectrin [6]. In zwitterionic film, however, the 
insertion of DYS R16-21 occurs up to 31 mN/m. This is probably because the protein’s 
orientation is not driven by electrostatic interactions and because its flexibility allows for 
penetration of the films even at higher surface pressures.  
When comparing the anionic monolayer insertion of the previously-studied fragments DYS 
R1-3, DYS R11-15 and DYS R20-24 to that of the DYS R16-21 studied here, different 
behaviors are seen, thus demonstrating that these fragments are not interchangeable as had 
been stated [51]. Indeed, at 30 mN/m, only DYS R11-15 inserts into the monolayer (∆π = 
+2 mN/m) [49], whereas both DYS R16-21 and R20-24 stayed at the head group level [12].  
At 20 mN/m, a gradient seems to occur along the central domain, with greater insertion for 
fragments from the N- to C-terminal ends (∆π =7 mN/m for DYS R1-3, 6 mN/m for DYS 
R11-15, and 5 mN/m for DYS R16-21 and DYS R20-24). This intriguing observation must 
be further studied to decipher whether it has a physiological significance. It would be 
especially interesting to understand the relationship between the variation in sarcolemmal 
lateral pressure during muscle elongation/contraction, and the number or position of 
anchoring points along the protein. Interestingly, it has been reported that binding of spectrin 
to phosphatidylserine in the inner membrane increases the mechanical stability of red blood 
cell membranes [52]. 
We examined dystrophin/lipid/CHOL interactions because of cholesterol presence in the 
membrane and of its impact on the membrane’s physical properties. Moreover we report the 
existence of a specific amino-acid sequence called CRAC (cholesterol recognition amino-
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acid consensus) and involved in CHOL binding [30, 53]. Like spectrin [54, 55], dystrophin 
has been shown to be associated in vivo to detergent-resistant membranes [56] and the 
interaction between β-DG and dystrophin is weakened by CHOL depletion [21]. The impact 
of CHOL on the structural and lateral organization of lipid layers is highly-documented [27, 
57, 58], in particular its role as head group spacer and its usual localization in the condensed 
phase formed by DPPC [26]. In addition, several monolayer experiments have shown 
complex formation between CHOL and phosphatidylserine, an important component of the 
inner leaflet [59]. Our study was performed at 15 % of CHOL since 10 to 20 % CHOL have 
been shown to increase spectrin insertion in phosphatidylethanolamine/phosphatidylcholine 
monolayers [10] and also because this concentration is known to preserve lateral phase 
separation [60]. At the lower initial surface pressure (20 mN/m), macroscopic measurements 
(π, ∆) were unmodified in presence of CHOL, but topographic images revealed an increase in 
the lateral size and height of protein protrusions, indicating changes in the molecular 
organization of DYS R16-21 within the lipid monolayers. CHOL favors lateral protein-
protein interactions, and since the lipids are in fluid phase, it increases steric packing in the 
hydrophobic part, limiting deep anchoring. In the DOPC/DPPC mixture, LC domain 
fragmentation is induced by the protein. DYS R16-21 insertion might induce local disorders 
in the lateral packing of the acyl chains. These hydrophobic mismatch defects   result in 
lateral fragmentation of these domains, and this phenomenon is amplified by the presence of 
CHOL[61, 62]. At a higher initial surface pressure (πi=30 mN/m), CHOL amplifies protein 
insertion into lipid monolayers and favors an homogeneous organization of the protein in 
both LC and LE domains. Indeed, the sterol polar head group is small compared to choline or 
serine, while the hydrophobic part at this pressure is similar to that of a phosphatidylcholine-
saturated chain [24], thus CHOL plays the role of head group spacer. This promotes a deeper 
and more homogenous lipid insertion. The DOPS/DYS R16-21 electrostatic interactions are 
modified by CHOL. This could be linked either to PS/CHOL complex formation as suggested 
by Radhakrishnan et al [59] or to specific DYS R16-21/CHOL interactions.  
Bio-informatics analysis of the DYS R16-21 amino acid sequence revealed two occurrences 
of the CRAC sequence  –(L/V)–(X)1–5–Y–(X)1–5–(R/K)- [30]. CRAC sequences are also 
present in spectrin and in other dystrophin fragments (Table S2). These patterns in DYS R16-
21 are easily accessible for interaction at the protein surface. Not only has CRAC been 
identified in many proteins that interact with cholesterol, but it has been more widely 
suggested to be related to protein propensity for interaction with cholesterol-rich lipid 
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domains [63]. CRAC motifs are often reported in membrane proteins, but are compatible 
with peripheral proteins and was also reported in a secreted toxin [64].  
 
 
 
5. Conclusion 
Our results highlight the fact that dystrophin fragments, and here especially DYS R16-21, 
can interact directly with monolayers at high surface pressure, at low fluidity, and in the 
presence of anionic lipids. We further show that the presence of dystrophin close to the 
membrane is probably not due only to a link with β-DG but also thanks to its own sub-part 
membrane-binding properties. It has now to be tested whether our in vitro results may be 
transposed in vivo. Does formation of direct interactions between dystrophin and cholesterol-
rich nano-domains stabilize the dystrophin/β-DG/sarcolemma in muscular cells? If so, 
cholesterol-rich domains in the inner sarcolemma layer could prevent ejection of dystrophin 
under surface pressure variations due to contraction/elongation cycles and contribute to 
sarcolemma resistance.  
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FIGURES LEGENDS 
 
Figure 1: DYS R16-21 sub-domain purification and secondary structure analysis. (left) 10 % 
SDS polyacrylamide gel of DYS R16-21 obtained after purification. Lane M is the protein 
ladder. (right) Circular dichroism measurements of 1.5 µM of DYS R16-21 in TNE buffer 
(pH 7.5) at 20°C. 
 
Figure 2: DYS R16-21 adsorption at the air-liquid interface. (A) Final surface pressure 
reached at the end of the adsorption kinetics versus DYS R16-21 subphase concentrations. 
Arrow indicates π reached for protein subphase concentration of 0.03 µM (B) Adsorption 
kinetics of DYS R16-21 at air-liquid interface for the subphase concentration of 0.03 µM, 
surface pressure (+), and ellipsometric angle (o). (C) AFM topographic image of transferred 
DYS R16-21 monolayer at the end of the kinetics (5 h). Surface pressure was 20 mN/m. Scan 
size 5µm x 5µm, z scale 10Å. 
 
Figure 3: Overpressure induced by adsorption of DYS R16-21 at air/lipid interface versus the 
initial lipid surface pressures of DOPC/DOPS (full line) and DOPC/DPPC (dotted line). 
Arrows indicate the values of maximal insertion pressures (MIP). The subphase concentration 
of DYS R16-21 was 0.03 µM. 
 
Figure 4: Characterization of DYS R16-21 at the initial lipid surface pressure of 20 mN/m. 
(A) Variations of the surface pressure (Δπ) and of the ellipsometric angle (δΔ) induced by 
DYS R16-21 adsorption on phospholipid monolayers (black) and phospholipid/CHOL 
monolayers (gray). (B-H) Typical AFM topographic images of monolayers as indicated on 
the panels. Scan size 5µm x 5µm for images B-F and H, and 2 µm x 2 µm for image G. Z-
range 80 Å. When present, DYS R16-21 subphase concentration is 0.03 µM, CHOL 15 %. 
LE, liquid-expanded phase; LC, liquid-condensed phase. 
 
Figure 5: Characterization of DYS R16-21at an initial lipid surface pressure of 30 mN/m. (A) 
Variations of the surface pressure (Δπ) and of the ellipsometric angle (δΔ) induced by DYS 
R16-21 absorption on phospholipid (black) and phospholipids/CHOL monolayers (gray). (B-
H) Typical AFM topographic images of monolayers as indicated on the panels. Scan size 
5µm x 5µm for images B-G and 2 µm x 2 µm for image H. Z-range 80 Å. When present, 
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DYS R16-21 subphase concentration is 0.03 µM and CHOL, 15 %. LE, liquid-expanded 
phase; LC, liquid-condensed phase. 
 
Figure 6: Molecular modeling of DYS R16-21. The 3D structure of DYS R16-21 was created 
in I-TASSER. The hydrophobic potential at the molecular surface (top row) is colored by 
increasing hydrophobicity from green (polar) to yellow (hydrophobic). The electrostatic 
potential at the molecular surface (middle row) is colored by increasing levels from red (-) to 
blue (+). The N-terminus (R16) is located at the left of the molecules. Left and right images 
in the top rows are representations of a 180°-rotation along the molecule’s long axis. Bottom 
row: 3D structure of DYS R16-21 in cartoon representation. Each dystrophin repeat is a 
different grey. Amino acids of the CRAC (cholesterol recognition/interaction amino acid 
consensus) patterns are red. 
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CHOL cholesterol 
LE liquid expended  
LC liquid condensed 
AFM atomic force microscopy 
DYS dystrophin 
β-DG β-dystroglycan 
CRAC cholesterol recognition/interaction amino acid consensus 
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